Type 2 diabetes and polycystic ovary syndrome

被引：19

作者：

Legro, Richard S. ^{[1
]}

机构：

[1] Penn State Univ, Coll Med, MS Hershey Med Ctr, Dept Obstet & Gynecol, Hershey, PA 17033 USA

来源：

FERTILITY AND STERILITY | 2006年 / 86卷

关键词：

polycystic ovary syndrome; hyperandrogenism; insulin resistance; diabetes; anovulation;

D O I：

10.1016/j.fertnstert.2006.04.010

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Women with polycystic ovary. syndrome (PCOS) have multiple factors that contribute to increased diabetes risk, including: insulin resistance, beta-cell dysfunction, obesity, especially centripetal obesity, family history of type 2 diabetes, and personal history of gestational-diabetes. Additionally there is some evidence to suggest that polycystic ovaries and chronic anovulation per se are risk factors. Identifying glucose intolerance and treating it are important aspects of the, care for women with PCOS.

引用

页码：S16 / S17

页数：2

共 50 条

[21] The presence of polycystic ovary syndrome increases the risk of maternal but not neonatal complications in women with type 2 diabetes in pregnancy
Atkins, Paul
Tomlinson, George
Feig, Denice S.
[J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (01)
[22] Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome
Sofia Lazaridou
Konstantinos Dinas
Konstantinos Tziomalos
[J]. Hormones, 2017, 16 : 373 - 380
[23] Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
Zhao, Xiaomiao
Zhong, Junmin
Mo, Yaqin
Chen, Xiaoli
Chen, Yaxiao
Yang, Dongzi
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 108 (02) : 148 - 151
[24] Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
Rodgers, Raymond J.
Avery, Jodie C.
Moore, Vivienne M.
Davies, Michael J.
Azziz, Ricardo
Stener-Victorin, Elisabet
Moran, Lisa J.
Robertson, Sarah A.
Stepto, Nigel K.
Norman, Robert J.
Teede, Helena J.
[J]. ENDOCRINE CONNECTIONS, 2019, 8 (03): : R71 - R75
[25] Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome
Lazaridou, Sofia
Dinas, Konstantinos
Tziomalos, Konstantinos
[J]. HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2017, 16 (04): : 373 - 380
[26] Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome
Henney, Alex E.
Gillespiec, Conor S.
Lai, Jonathan Y. M.
Schofield, Pieta
Riley, David R.
Caleyachetty, Rishi
Barber, Thomas M.
Miras, Alexander D.
Dobbie, Laurence J.
Hughes, David M.
Alam, Uazman
Hydes, Theresa J.
Cuthbertson, Daniel J.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, : 1235 - 1246
[27] Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
Livadas, Sarantis
Paparodis, Rodis
Anagnostis, Panagiotis
Gambineri, Alessandra
Bjekic-Macut, Jelica
Petrovic, Tijana
Yildiz, Bulent O.
Micic, Dragan
Mastorakos, George
Macut, Djuro
[J]. DIAGNOSTICS, 2023, 13 (12)
[28] Polycystic Ovary Syndrome (PCOS) in Juvenile and Adult Type 1 Diabetes in a German/Austrian Cohort
Reinauer, Christina
Bollow, Esther
Froehlich-Reiterer, Elke
Laubner, Katharina
Bergis, Dominik
Schoefl, Christof
Kempe, Hans-Peter
Hummel, Michael
Hennes, Pia
Gollisch, Katja
Haberland, Holger
Datz, Nicolin
Meissner, Thomas
Holl, Reinhard W.
[J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (10) : 661 - 668
[29] Polycystic Ovary Syndrome
Meier, Renate K.
[J]. NURSING CLINICS OF NORTH AMERICA, 2018, 53 (03) : 407 - +
[30] Polycystic ovary syndrome in pediatric obesity and diabetes
Dondi, Elena
Tufano, Maria
Vigone, Maria C.
Lucaccioni, Laura
Pozzobon, Gabriella
Ubertini, Graziamaria
Mozzillo, Enza
Delvecchio, Maurizio
[J]. MINERVA PEDIATRICS, 2021, 73 (06): : 523 - 536

← 1 2 3 4 5 →